← Leaderboards
Ron C Gaba
University Of Illinois At Chicago
$1,001,057
Attributed
$1,842,214
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $657.1K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,842,214 · 3
By mechanism
R01$1,300,171 · 1
R21$382,143 · 1
R03$159,900 · 1
Top collaborators
- Kejia Cai2 shared
- Kyle Schachtschneider2 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Nissim Hay$25,480,567
- Clifton David Fuller$6,957,707
- Alexander Richard Terry$240,850
- Kyle Schachtschneider$1,191,072
- Arnon Lavie$5,954,044
Others in their field
Other Emerging Leaders on “Tumor Biology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$295,430,169
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$76,301,002
- Leonard Freedmand · Leidos Biomedical Research, Inc.$59,948,921
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
Tumor BiologyFamily SuidaePrimary Carcinoma Of The Liver CellsTumorResearch StudyMalignant Neoplasm Of LiverLiverMetabolismTransgenic OrganismsTreatment ResponseDiagnosisCancer ModelPrimary Malignant Neoplasm Of LiverMalignant NeoplasmsCessation Of LifeIncidenceImageInnovationGrantGenesGrowthInsightFutureAnimal Model
Grant awards (6)
Noninvasive High-Resolution Mapping of HCC Tumor Biology Predictive of Malignancy$643,066
R01 · FY2025 · CA
Noninvasive High-Resolution Mapping of HCC Tumor Biology Predictive of Malignancy$657,105
R01 · FY2024 · CA
Implications of Driver Mutations for Progression of Hepatocellular Carcinoma$243,090
R21 · FY2020 · CA · contact PI
Validation of an Advanced Magnetic Resonance Imaging Protocol for Tracking Liver Cancer and Cirrhosis in a Transgenic Porcine Tumorigenic Platform$79,950
R03 · FY2020 · CA · contact PI
Implications of Driver Mutations for Progression of Hepatocellular Carcinoma$139,053
R21 · FY2019 · CA · contact PI
Validation of an Advanced Magnetic Resonance Imaging Protocol for Tracking Liver Cancer and Cirrhosis in a Transgenic Porcine Tumorigenic Platform$79,950
R03 · FY2019 · CA · contact PI